Big news came as soon as the stock market closed: Big change in the management of the company which gave 184% return in 3 years, keep a close eye on the stock tomorrow.

In the last moments of Indian stock market trading, a very important and big news has come out from the healthcare sector. Agilus Diagnostics, a wholly owned subsidiary of Fortis Healthcare, has announced a major reshuffle in its top leadership. The company has informed in its stock exchange filing that it has completed the appointment process of its new Managing Director (MD) and Chief Executive Officer (CEO). The effect of this move of this company, which has given excellent returns of more than 184% to investors in the last three years, can be seen on its shares in the next trading session. After the resignation of Dr. Anand K, Vijendra Singh became the new Chief of Agillus Diagnostics. According to the official information shared by the company, Vijendra Singh has taken over as the new MD and CEO of the company from July 20, 2026. This new appointment has taken place after Dr. Anand K left the post. Dr. Anand, after a successful association with Agillus Diagnostics for nearly six years, has now retired to pursue new career opportunities. Market analysts believe that the impact of this leadership change, which came at the end of trading hours, will be clearly visible on the movement of shares of the company and Fortis Healthcare as soon as the market opens tomorrow. 30 years of experience in diagnostics and FMCG sector: Know who is Vijendra Singh? Vijendra Singh, who is heading Agillus Diagnostics, is a well-known name in the healthcare and consumer industry. He has vast managerial experience of over 30 years in the Diagnostics, Healthcare, Consumer Healthcare and FMCG sectors. Before this, he was holding the post of Chairman and Managing Director of Diagnum Healthcare. Apart from this, he has held important senior leadership roles in leading companies like Group CEO at Metropolis Healthcare, CEO at Healthiens and Dr. Lal PathLabs. He has also worked in leading companies such as Ranbaxy Consumer Healthcare, Bausch & Lomb and Blow Plast. Chairman Dr. Ashutosh Raghuvanshi expressed hope, the new CEO said – ‘The focus will be on innovation and reach’. Welcoming Vijendra Singh, MD-CEO of Fortis Healthcare and Chairman of Agillus, Dr. Ashutosh Raghuvanshi said that he has an excellent track record of taking the diagnostic business to new heights, achieving operational excellence and generating long-term value for shareholders. Commenting on his appointment, Vijendra Singh said that he is very excited to join the company in this rapidly changing diagnostic sector. He will focus on expanding access to high-quality diagnostic services across the country, strengthening operational efficiency and driving customer trust. Country’s huge network: The company handles more than 410 labs and more than 3700 touch points. Let us tell you that Agillus Diagnostics is one of India’s leading pathology and diagnostic service providers. The company’s nationwide presence can be gauged from the fact that it has a vast network of more than 410 state-of-the-art laboratories, more than 3,700 customer touch points and more than 12,000 direct pick-up points across the country. In such a situation, with strong leadership, the company is moving towards strengthening its position in the diagnostic market in the coming times.